glp 1 oral drug Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients With FDA approval of Wegovy

Moore, Edie, Abram

Tirzepatide in obesitythe surmount clinical study program The GLP-1RA liraglutide has been approved for the pharmacological treatment of obesity and various other GLP-1RA may be approved in the future for this indication as well (3941, 81)

Apart from this, newer versions of the guidelines that recommend the use of these drugs in certain patient populations have added to their market position

But for many, the excitement of seeing the number on the scale go down has been tempered by an unexpected surprise: increased hair shedding

It works through multiple mechanisms, increasing blood vessel formation around follicles, reducing inflammation, stimulating collagen synthesis in the dermal papilla, and blocking 5-alpha reductase, the enzyme that converts testosterone to the follicle-damaging DHT